Narikawa K - Search Results

1

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y. Nakashima I, et al. Among authors: narikawa k. J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1073-5. doi: 10.1136/jnnp.2005.080390. Epub 2006 Feb 27. J Neurol Neurosurg Psychiatry. 2006. PMID: 16505005 Free PMC article.

2

CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis.

Narikawa K, Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Narikawa K, et al. J Neuroimmunol. 2004 Apr;149(1-2):182-6. doi: 10.1016/j.jneuroim.2003.12.010. J Neuroimmunol. 2004. PMID: 15020078

3

Absence of IgG1 response in the cerebrospinal fluid of relapsing neuromyelitis optica.

Nakashima I, Fujihara K, Fujimori J, Narikawa K, Misu T, Itoyama Y. Nakashima I, et al. Among authors: narikawa k. Neurology. 2004 Jan 13;62(1):144-6. doi: 10.1212/wnl.62.1.144. Neurology. 2004. PMID: 14718720

4

CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.

Narikawa K, Fujihara K, Misu T, Feng J, Fujimori J, Nakashima I, Miyazawa I, Saito H, Sato S, Itoyama Y. Narikawa K, et al. J Neuroimmunol. 2005 Feb;159(1-2):177-82. doi: 10.1016/j.jneuroim.2004.10.011. Epub 2004 Dec 15. J Neuroimmunol. 2005. PMID: 15652417

5

Soluble CD26 and CD30 levels in CSF and sera of patients with relapsing neuromyelitis optica.

Narikawa K, Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Narikawa K, et al. J Neurol. 2006 Jan;253(1):111-3. doi: 10.1007/s00415-005-0901-1. Epub 2005 Jul 18. J Neurol. 2006. PMID: 16021350 No abstract available.

6

Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.

Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, Nishida H, Komori T, Seki M, Komatsu T, Nakamagoe K, Ikeda T, Yoshida M, Takahashi T, Ono H, Nishiyama S, Kuroda H, Nakashima I, Suzuki H, Bradl M, Lassmann H, Fujihara K, Aoki M; Japan MOG-antibody Disease Consortium. Takai Y, et al. Among authors: narikawa k. Brain. 2020 May 1;143(5):1431-1446. doi: 10.1093/brain/awaa102. Brain. 2020. PMID: 32412053

7

Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease.

Miyazawa I, Abe T, Narikawa K, Feng J, Misu T, Nakashima I, Fujimori J, Tamai M, Fujihara K, Itoyama Y. Miyazawa I, et al. Among authors: narikawa k. J Neuroimmunol. 2005 Jan;158(1-2):240-4. doi: 10.1016/j.jneuroim.2004.07.014. J Neuroimmunol. 2005. PMID: 15589059

8

Periodic episodes of aphasia as an unusual manifestation of partial status epilepticus.

Hasegawa T, Shiga Y, Narikawa K, Jin K, Fujihara K, Takeda A, Itoyama Y. Hasegawa T, et al. Among authors: narikawa k. J Clin Neurosci. 2005 Sep;12(7):820-2. doi: 10.1016/j.jocn.2004.09.024. J Clin Neurosci. 2005. PMID: 16153849

9

[Successful treatment of emotional disturbances following non-herpetic limbic encephalitis by serotonergic agents. A case report].

Narikawa K, Hasegawa T, Takeda A, Shiga Y, Itoyama Y. Narikawa K, et al. Rinsho Shinkeigaku. 2001 Nov;41(11):805-8. Rinsho Shinkeigaku. 2001. PMID: 12080614 Japanese.

10

Familial inclusion body myositis: a report on two Japanese sisters.

Tateyama M, Saito N, Fujihara K, Shiga Y, Takeda A, Narikawa K, Hasegawa T, Taguchi Y, Sakuma R, Onodera Y, Ohnuma A, Tobita M, Itoyama Y. Tateyama M, et al. Among authors: narikawa k. Intern Med. 2003 Oct;42(10):1035-8. doi: 10.2169/internalmedicine.42.1035. Intern Med. 2003. PMID: 14606722 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters